Works matching IS 21686149 AND DT 2020 AND VI 77 AND IP 2

Results: 28
    1
    2
    3

    JAMA Neurology.

    Published in:
    JAMA Neurology, 2020, v. 77, n. 2, p. 150, doi. 10.1001/jamaneurol.2019.3184
    Publication type:
    Article
    4

    Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial.

    Published in:
    JAMA Neurology, 2020, v. 77, n. 2, p. 164, doi. 10.1001/jamaneurol.2019.3762
    By:
    • Howard, Robert;
    • Zubko, Olga;
    • Bradley, Rosie;
    • Harper, Emma;
    • Pank, Lynn;
    • O'Brien, John;
    • Fox, Chris;
    • Tabet, Naji;
    • Livingston, Gill;
    • Bentham, Peter;
    • McShane, Rupert;
    • Burns, Alistair;
    • Ritchie, Craig;
    • Reeves, Suzanne;
    • Lovestone, Simon;
    • Ballard, Clive;
    • Noble, Wendy;
    • Nilforooshan, Ramin;
    • Wilcock, Gordon;
    • Gray, Richard
    Publication type:
    Article
    5
    6

    Hail Mary.

    Published in:
    2020
    By:
    • Nash, Ira S.
    Publication type:
    Opinion
    7

    Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial.

    Published in:
    JAMA Neurology, 2020, v. 77, n. 2, p. 215, doi. 10.1001/jamaneurol.2019.3812
    By:
    • Tsai, Richard M.;
    • Miller, Zachary;
    • Koestler, Mary;
    • Rojas, Julio C.;
    • Ljubenkov, Peter A.;
    • Rosen, Howard J.;
    • Rabinovici, Gil D.;
    • Fagan, Anne M.;
    • Cobigo, Yann;
    • Brown, Jesse A.;
    • Jung, Joo In;
    • Hare, Emma;
    • Geldmacher, David S.;
    • Natelson-Love, Marissa;
    • McKinley, Emily C.;
    • Luong, Phi N.;
    • Chuu, Emmeline L.;
    • Powers, Ryan;
    • Mumford, Paige;
    • Wolf, Amy
    Publication type:
    Article
    8

    Associations Between Vascular Risk Across Adulthood and Brain Pathology in Late Life: Evidence From a British Birth Cohort.

    Published in:
    JAMA Neurology, 2020, v. 77, n. 2, p. 175, doi. 10.1001/jamaneurol.2019.3774
    By:
    • Lane, Christopher A.;
    • Barnes, Josephine;
    • Nicholas, Jennifer M.;
    • Sudre, Carole H.;
    • Cash, David M.;
    • Malone, Ian B.;
    • Parker, Thomas D.;
    • Keshavan, Ashvini;
    • Buchanan, Sarah M.;
    • Keuss, Sarah E.;
    • James, Sarah-Naomi;
    • Lu, Kirsty;
    • Murray-Smith, Heidi;
    • Wong, Andrew;
    • Gordon, Elizabeth;
    • Coath, William;
    • Modat, Marc;
    • Thomas, David;
    • Richards, Marcus;
    • Fox, Nick C.
    Publication type:
    Article
    9
    10
    11

    Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials.

    Published in:
    JAMA Neurology, 2020, v. 77, n. 2, p. 199, doi. 10.1001/jamaneurol.2019.3988
    By:
    • Wessels, Alette M.;
    • Tariot, Pierre N.;
    • Zimmer, Jennifer A.;
    • Selzler, Katherine J.;
    • Bragg, Sonja M.;
    • Andersen, Scott W.;
    • Landry, John;
    • Krull, James H.;
    • Downing, AnnCatherine M.;
    • Willis, Brian A.;
    • Shcherbinin, Sergey;
    • Mullen, Jamie;
    • Barker, Peter;
    • Schumi, Jennifer;
    • Shering, Craig;
    • Matthews, Brandy R.;
    • Stern, Robert A.;
    • Vellas, Bruno;
    • Cohen, Sharon;
    • MacSweeney, Emer
    Publication type:
    Article
    12

    Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies.

    Published in:
    JAMA Neurology, 2020, v. 77, n. 2, p. 184, doi. 10.1001/jamaneurol.2019.3365
    By:
    • Luna, Gustavo;
    • Alping, Peter;
    • Burman, Joachim;
    • Fink, Katharina;
    • Fogdell-Hahn, Anna;
    • Gunnarsson, Martin;
    • Hillert, Jan;
    • Langer-Gould, Annette;
    • Lycke, Jan;
    • Nilsson, Petra;
    • Salzer, Jonatan;
    • Svenningsson, Anders;
    • Vrethem, Magnus;
    • Olsson, Tomas;
    • Piehl, Fredrik;
    • Frisell, Thomas
    Publication type:
    Article
    13
    14

    Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis.

    Published in:
    JAMA Neurology, 2020, v. 77, n. 2, p. 234, doi. 10.1001/jamaneurol.2019.3283
    By:
    • Andorrà, Magí;
    • Alba-Arbalat, Salut;
    • Camos-Carreras, Anna;
    • Gabilondo, Iñigo;
    • Fraga-Pumar, Elena;
    • Torres-Torres, Ruben;
    • Pulido-Valdeolivas, Irene;
    • Tercero-Uribe, Ana I.;
    • Guerrero-Zamora, Ana M.;
    • Ortiz-Perez, Santiago;
    • Zubizarreta, Irati;
    • Sola-Valls, Nuria;
    • Llufriu, Sara;
    • Sepulveda, Maria;
    • Martinez-Hernandez, Eugenia;
    • Armangue, Thais;
    • Blanco, Yolanda;
    • Villoslada, Pablo;
    • Sanchez-Dalmau, Bernardo;
    • Saiz, Albert
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22

    Highlights.

    Published in:
    JAMA Neurology, 2020, v. 77, n. 2, p. 149, doi. 10.1001/jamaneurol.2019.3183
    Publication type:
    Article
    23
    24
    25
    26
    27
    28